March 12, 2020

Mentice Introduces Its Coronary Intermediate Simulation Software

March 12, 2020—Mentice AB announced the introduction of Coronary Intermediate, which is the latest software addition to the company's Coronary Product Portfolio of simulation solutions. Coronary Intermediate follows the introduction of Coronary Essentials at the 20th International Meeting on Simulation in Healthcare held in January in San Diego, California.

According to Mentice, the software helps improve user proficiency by incorporating an extensive library of cases that present various degrees of difficulty. To better handle complexities encountered with real patients, the solution offers proctors and attending physicians the ability to remotely and introduce complications in real-time using a tablet via the Mentice Proctor iOS app.

Professor Wolfram Voelker, MD, commented in the company's announcement, “It is critical to use simulation to train fellows and students on treating real patients with myocardial infarction. In the case of myocardial infarction, time is muscle and it is of utter importance to act quickly, effectively, and avoid complications. In my opinion, Coronary Intermediate can help build competence in performing such interventions." Prof. Voelker is Deputy Director of the Medical Clinic and Polyclinic of the University Hospital of Würzburg, Germany.

Additionally, the company advised that interventional cardiology fellows who already possess elementary skills in angiography and angioplasty can use the Mentice Coronary Intermediate to improve their proficiency levels.

According to the company, the Mentice Coronary Intermediate software can be used to:

  • Enhance decision-making processes to address complications with confidence
  • Improve interpretation and familiarize the user with intravascular imaging
  • Reduce proctoring time by incorporating built-in expert guidance for self-learning
  • Track individual progress and compare outcomes against expert benchmarks


March 13, 2020

ACC.20/WCC Announces Virtual Experience

March 11, 2020

Study Evaluates Late Cerebrovascular Events After TAVR